Transmission dynamics and mutational prevalence of the novel Severe acute respiratory syndrome coronavirus-2 Omicron Variant of Concern
被引:31
|
作者:
Saxena, Shailendra K.
论文数: 0引用数: 0
h-index: 0
机构:
King Georges Med Univ KGMU, Fac Med, Ctr Adv Res CFAR, Lucknow 226003, Uttar Pradesh, India
World Soc Virol WSV, Al Taif, Saudi Arabia
Indian Virol Soc IVS, New Delhi, IndiaKing Georges Med Univ KGMU, Fac Med, Ctr Adv Res CFAR, Lucknow 226003, Uttar Pradesh, India
Saxena, Shailendra K.
[1
,2
,3
]
Kumar, Swatantra
论文数: 0引用数: 0
h-index: 0
机构:
King Georges Med Univ KGMU, Fac Med, Ctr Adv Res CFAR, Lucknow 226003, Uttar Pradesh, India
World Soc Virol WSV, Al Taif, Saudi ArabiaKing Georges Med Univ KGMU, Fac Med, Ctr Adv Res CFAR, Lucknow 226003, Uttar Pradesh, India
Kumar, Swatantra
[1
,2
]
Ansari, Saniya
论文数: 0引用数: 0
h-index: 0
机构:
King Georges Med Univ KGMU, Fac Med, Ctr Adv Res CFAR, Lucknow 226003, Uttar Pradesh, India
World Soc Virol WSV, Al Taif, Saudi ArabiaKing Georges Med Univ KGMU, Fac Med, Ctr Adv Res CFAR, Lucknow 226003, Uttar Pradesh, India
Ansari, Saniya
[1
,2
]
Paweska, Janusz T.
论文数: 0引用数: 0
h-index: 0
机构:
World Soc Virol WSV, Al Taif, Saudi Arabia
Natl Inst Communicable Dis, Natl Hlth Lab Serv, Ctr Emerging Zoonot & Parasit Dis, PB 104, Johannesburg, South AfricaKing Georges Med Univ KGMU, Fac Med, Ctr Adv Res CFAR, Lucknow 226003, Uttar Pradesh, India
Paweska, Janusz T.
[2
,4
]
Maurya, Vimal K.
论文数: 0引用数: 0
h-index: 0
机构:
King Georges Med Univ KGMU, Fac Med, Ctr Adv Res CFAR, Lucknow 226003, Uttar Pradesh, India
World Soc Virol WSV, Al Taif, Saudi ArabiaKing Georges Med Univ KGMU, Fac Med, Ctr Adv Res CFAR, Lucknow 226003, Uttar Pradesh, India
Maurya, Vimal K.
[1
,2
]
Tripathi, Anil K.
论文数: 0引用数: 0
h-index: 0
机构:
King Georges Med Univ KGMU, Fac Med, Ctr Adv Res CFAR, Lucknow 226003, Uttar Pradesh, IndiaKing Georges Med Univ KGMU, Fac Med, Ctr Adv Res CFAR, Lucknow 226003, Uttar Pradesh, India
Tripathi, Anil K.
[1
]
Abdel-Moneim, Ahmed S.
论文数: 0引用数: 0
h-index: 0
机构:
Taif Univ, Coll Med, Dept Microbiol, Al Taif, Saudi ArabiaKing Georges Med Univ KGMU, Fac Med, Ctr Adv Res CFAR, Lucknow 226003, Uttar Pradesh, India
Abdel-Moneim, Ahmed S.
[5
]
机构:
[1] King Georges Med Univ KGMU, Fac Med, Ctr Adv Res CFAR, Lucknow 226003, Uttar Pradesh, India
[2] World Soc Virol WSV, Al Taif, Saudi Arabia
[3] Indian Virol Soc IVS, New Delhi, India
[4] Natl Inst Communicable Dis, Natl Hlth Lab Serv, Ctr Emerging Zoonot & Parasit Dis, PB 104, Johannesburg, South Africa
[5] Taif Univ, Coll Med, Dept Microbiol, Al Taif, Saudi Arabia
The novel Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) variant, Omicron (PANGO lineage B.1.1.529) is being reported from all around the world. The WHO has categorized Omicron as a Variant of Concern (VOC) considering its higher transmissibility and infectivity, vaccine breakthrough cases. As of January 6, 2022, Omicron has been reported in at least 149 countries. Therefore, this study was planned to investigate the transmission dynamics and mutational prevalence of the novel SARS-CoV-2 Omicron variant. The transmission dynamics and Omicron SARS-CoV-2 divergence was studied using GISAID and Nextstrain which provides information about the genetic sequences, epidemiological, geographical, and species-specific data of human, avian, and animal viruses. Further, the mutation prevalence in spike glycoprotein of Omicron was studied, and the frequency of the crucial mutations was compared with the other prevalent VOCs. The transmission dynamics suggest that the Omicron was first identified in South Africa and then it was reported in the United Kingdom followed by the United States and Australia. Further, our phylogenetic analysis suggests that Omicron (BA.1) was clustered distinctly from the other VOCs. In the Spike glycoprotein, the Omicron (B.1.1.529) demonstrates critical 32 amino acid changes. This study may help us to understand mutational hotspots, transmission dynamics, phylogenetic divergence, effect on testing and immunity, which shall promote the progress of the clinical application and basic research.
机构:
Cincinnati Childrens Hosp Med Ctr, Div Infect Dis, Cincinnati, OH 45229 USA
Cincinnati Childrens Hosp Med Ctr, Div Clin Pharmacol, Cincinnati, OH 45229 USACincinnati Childrens Hosp Med Ctr, Div Infect Dis, Cincinnati, OH 45229 USA
Murphy, Mark E.
Clay, Gwendolyn
论文数: 0引用数: 0
h-index: 0
机构:
Cincinnati Childrens Hosp Med Ctr, Div Rheumatol, Dept Pediat, Cincinnati, OH 45229 USACincinnati Childrens Hosp Med Ctr, Div Infect Dis, Cincinnati, OH 45229 USA
Clay, Gwendolyn
Danziger-Isakov, Lara
论文数: 0引用数: 0
h-index: 0
机构:
Cincinnati Childrens Hosp Med Ctr, Div Infect Dis, Cincinnati, OH 45229 USA
Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH USACincinnati Childrens Hosp Med Ctr, Div Infect Dis, Cincinnati, OH 45229 USA
Danziger-Isakov, Lara
Schulert, Grant
论文数: 0引用数: 0
h-index: 0
机构:
Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH USACincinnati Childrens Hosp Med Ctr, Div Infect Dis, Cincinnati, OH 45229 USA
Schulert, Grant
Paulsen, Grant C.
论文数: 0引用数: 0
h-index: 0
机构:
Cincinnati Childrens Hosp Med Ctr, Div Infect Dis, Cincinnati, OH 45229 USA
Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH USACincinnati Childrens Hosp Med Ctr, Div Infect Dis, Cincinnati, OH 45229 USA
机构:
Univ Tehran Med Sci, Sch Publ Hlth, Dept Virol, Tehran, Iran
Univ Tehran Med Sci, Res Ctr Clin Virol, Tehran, IranUniv Tehran Med Sci, Sch Publ Hlth, Dept Virol, Tehran, Iran
Zandi, Milad
Soltani, Saber
论文数: 0引用数: 0
h-index: 0
机构:
Univ Tehran Med Sci, Sch Publ Hlth, Dept Virol, Tehran, Iran
Univ Tehran Med Sci, Res Ctr Clin Virol, Tehran, IranUniv Tehran Med Sci, Sch Publ Hlth, Dept Virol, Tehran, Iran